“I Just Want To Live”: A Pregnant Surrogate In Ukraine Speaks Out
By Lizzie Cernik and Anastasiia Levchenko,
Refinery29
| 03. 16. 2022
Kharkiv, Ukraine: 13 March, 2022
Photo by Fotoreserg
The day before war broke out in Ukraine, 33-year-old Tanya [name changed to protect identity] was visiting a hospital in Cherkasy, a city in the center of the country, to check on the health of her unborn twins. She was unable to return to her hometown near Kirovograd due to the ongoing violence and quickly moved to an apartment in the city with her husband and two children.
"I started getting severe pregnancy sickness (hyperemesis) just as the war started," Tanya says over the phone from Ukraine. "I’m now almost 10 weeks pregnant and I’ve struggled to eat anything or cook and care for my children properly because it’s so bad, which has made things even more difficult. I just hope I can stay where I am until I have the babies."
Being pregnant in a war zone is a terrifying prospect for anyone but Tanya’s situation is more complicated than most. She is one of approximately 1,000 surrogates in Ukraine who are currently pregnant with the...
Related Articles
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Staff, ScienceDaily | 01.05.2026
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off. The research shows that small chemical markers attached to DNA
...
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In 2025, we published up to four posts every month, written by 12 authors (staff, consultants and allies), some in collaboration and one simply credited to CGS.
These titles are presented in chronological order, except for three In Memoriam notices, which follow. Many more posts that are worth your time can be found in the archive. Scroll down and “VIEW...
By Jonathan Matthews, GMWatch | 12.11.2025
In our first article in this series, we investigated the dark PR tactics that have accompanied Colossal Bioscience’s de-extinction disinformation campaign, in which transgenic cloned grey wolves have been showcased to the world as resurrected dire wolves – a...
